| Entry |
|
|---|
| Name |
Lifirafenib (USAN/INN) |
|---|
| Formula |
C25H17F3N4O3
|
|---|
| Exact mass |
478.1253
|
|---|
| Mol weight |
478.42
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
TKL group
BRAF
D11410 Lifirafenib (USAN/INN)
Receptor tyrosine kinases (RTK)
EGFR family
EGFR
D11410 Lifirafenib (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 35
1 C8x C 5.8800 -16.9400
2 C8y C 5.8800 -18.3400
3 C8x C 7.0700 -19.0400
4 C8y C 8.3300 -18.3400
5 C8y C 8.3300 -16.9400
6 C8x C 7.0700 -16.2400
7 C1d C 4.6900 -19.0400
8 N5x N 9.6600 -18.7600
9 C8y C 10.4300 -17.6400
10 N4x N 9.6600 -16.5200
11 C1y C 11.8300 -17.6400
12 C8y C 14.4900 -15.6100
13 C8y C 14.4900 -17.0100
14 C8x C 15.6800 -17.7100
15 C8y C 16.9400 -17.0100
16 C8x C 16.9400 -15.6100
17 C8x C 15.6800 -14.9100
18 O2x O 13.1600 -15.1900
19 C1y C 12.3200 -16.3100
20 C1y C 13.1600 -17.4300
21 O2a O 18.1300 -17.7100
22 C8y C 19.3900 -17.0100
23 C8x C 19.3900 -15.6100
24 C8y C 20.5800 -17.7100
25 C8y C 21.8400 -17.0100
26 N5x N 21.8400 -15.6100
27 C8x C 20.5800 -14.9100
28 C1x C 20.5800 -19.1100
29 C1x C 21.7700 -19.8100
30 C5x C 23.0300 -19.1100
31 N1x N 23.0300 -17.7100
32 O5x O 24.2200 -19.8800
33 X F 3.5000 -19.7400
34 X F 3.9900 -17.8500
35 X F 5.3900 -20.2300
BOND 41
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 4 8 1
9 8 9 2
10 9 10 1
11 5 10 1
12 11 9 1 #Down
13 12 13 2
14 13 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 12 17 1
19 12 18 1
20 18 19 1
21 19 20 1
22 20 13 1 #Up
23 11 20 1
24 19 11 1
25 15 21 1
26 21 22 1
27 23 22 2
28 22 24 1
29 24 25 2
30 25 26 1
31 26 27 2
32 23 27 1
33 24 28 1
34 28 29 1
35 29 30 1
36 30 31 1
37 25 31 1
38 30 32 2
39 7 33 1
40 7 34 1
41 7 35 1
|
|---|
